Ribbon Bio launched the Early Access Program for its MiroMine cell-free assembly kits in May 2026.
Public source
Publisher name
Public post
At Ribbon Bio we've been serving customers with our cell-free DNA for a little over 2 years now. We have a validated, efficient, and trusted process and an incredible pr…
Company
Ribbon Bio
Making The Impossible Possible
- Industry
- Biotechnology Research
- Location
- Vienna, AT
- Company size
- 51–200 employees
About Ribbon Bio
We are redefining scientific possibility with our algorithm-driven technology that produces pristine synthetic DNA molecules, enabling our partners to deliver a new generation of transformative solutions for the health of people and planet.
See moreLatest activity
Latest activity from Ribbon Bio
4 signals
People
Ribbon Bio appointed Jay Therrien as Chief Business Officer.
People
Ribbon Bio hired Jay Therrien as Chief Business Officer
Presence & Recognition
Ribbon Bio is hosting a webinar on September 10 featuring VP of Product Divya Vijay Pratheek and Matthew Youngblut from Flock Bio to explore bench-based, cell-free DNA production.
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
Telesis Bio
Telesis Bio introduced Gibson SOLA® to help bring the next step in-house for synthetic biology and drug discovery.
Products & Services
EditCo Bio
EditCo Bio launched an automated CRISPR platform designed to handle scale work by building and validating cell models across genes, cell backgrounds, and experimental conditions.
Products & Services
GBI Bio
GBI Bio introduced the SmartScale GMP, a 50g gene-to-DP service in 8 months at a fraction of traditional Phase 1 CDMO manufacturing costs.
Products & Services
Ginkgo Bioworks
Ginkgo Bioworks launched the CFPS Disulfide Premium portfolio, built for oxidative folding right out of the kit.
Products & Services
4basebio